Date | Time | Source | Announcement |
---|---|---|---|
26 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
25 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
24 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
23 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
22 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
19 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
18 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
17 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
16 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
15 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
12 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
10 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
08 Sep 2003 | 04:00 PM | Director Shareholding | |
08 Sep 2003 | 07:00 AM | Symbicort | |
04 Sep 2003 | 05:15 PM | Director Shareholding | |
04 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
01 Sep 2003 | 07:54 AM | Exanta Study | |
01 Sep 2003 | 07:01 AM | Atacand CHARM Study | |
27 Aug 2003 | 03:00 PM | Capital Group | |
13 Aug 2003 | 07:01 AM | Crestor | |
08 Aug 2003 | 01:30 PM | Patent Infringement - Mylan | |
24 Jul 2003 | 11:00 AM | Interim Results - part 2 0f 2 | |
24 Jul 2003 | 11:00 AM | Interim Results - part 1of 2 | |
23 Jul 2003 | 09:00 AM | Notice of Results | |
14 Jul 2003 | 11:15 AM | Exanta | |
10 Jul 2003 | 07:00 AM | Crestor | |
08 Jul 2003 | 04:00 PM | Director Shareholding | |
01 Jul 2003 | 01:30 PM | New Appointments | |
23 Jun 2003 | 09:36 AM | Exanta | |
23 Jun 2003 | 07:37 AM | Statement re Zoladex | |
02 Jun 2003 | 07:00 AM | Purchase of Own Securities | |
30 May 2003 | 07:00 AM | Purchase of Own Securities | |
28 May 2003 | 07:00 AM | Purchase of Own Securities | |
22 May 2003 | 07:00 AM | Purchase of Own Securities | |
21 May 2003 | 07:00 AM | Purchase of Own Securities | |
20 May 2003 | 07:01 AM | Crestor | |
20 May 2003 | 07:00 AM | Purchase of Own Securities | |
19 May 2003 | 12:00 PM | Director Shareholding | |
19 May 2003 | 07:00 AM | Purchase of Own Securities | |
15 May 2003 | 12:00 PM | Director Shareholding | |
13 May 2003 | 07:00 AM | Purchase of Own Securities | |
08 May 2003 | 03:00 PM | Capital Group | |
08 May 2003 | 07:00 AM | Purchase of Own Securities | |
06 May 2003 | 04:00 PM | Capital Group | |
06 May 2003 | 07:00 AM | Iressa | |
02 May 2003 | 11:59 AM | AGM Resolutiions | |
30 Apr 2003 | 04:24 PM | AGM Poll Votes | |
30 Apr 2003 | 11:00 AM | Directorate Change | |
30 Apr 2003 | 10:00 AM | 1st Quarter Results | |
30 Apr 2003 | 10:00 AM | 1st Quarter Results |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.